Trial Profile
Atlas of the evolution of psoriasis lesions under Remicade : A dynamic standardized photographic library of moderate to severe psoriasis subjects treated with infliximab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- Acronyms PHODYPSO
- Sponsors Merck Sharp & Dohme Corp.
- 06 Sep 2013 Trial association changed from Schering-Plough to Merck & Co as reported by ClinicalTrials.gov.
- 28 Jan 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 28 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.